Article 1
The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
Commission Implementing Regulation (EU) 2025/787 of 24 April 2025 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1,4-dimethylnaphthalene, amidosulfuron, bentazone, bixafen, clomazone, fenoxaprop-P, fludioxonil, fluoxastrobin, flutolanil, fluxapyroxad, gibberellic acid, gibberellins, halauxifen-methyl, mecoprop-P, paraffin oil, penthiopyrad, pirimiphos-methyl, propamocarb, propyzamide, prothioconazole, rimsulfuron, sedaxane and sulfoxaflor
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
ANNEX 1. Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (a) in the sixth column, expiration of approval, of row 57, Mecoprop-P, the date is replaced by ‘15 October 2027’; (b) in the sixth column, expiration of approval, of row 125, Rimsulfuron, the date is replaced by ‘15 August 2028’; (c) in the sixth column, expiration of approval, of row 154, Propamocarb, the date is replaced by ‘31 January 2027’; (d) in the sixth column, expiration of approval, of row 156, Pirimiphos-methyl, the date is replaced by ‘31 January 2027’; (e) in the sixth column, expiration of approval, of row 161, Fludioxonil, the date is replaced by ‘30 September 2026’; (f) in the sixth column, expiration of approval, of row 162, Clomazone, the date is replaced by ‘30 September 2026’; (g) in the sixth column, expiration of approval, of row 166, Fluoxastrobin, the date is replaced by ‘31 January 2027’; (h) in the sixth column, expiration of approval, of row 168, Prothioconazole, the date is replaced by ‘31 March 2027’; (i) in the sixth column, expiration of approval, of row 169, Amidosulfuron, the date is replaced by ‘30 November 2026’; (j) in the sixth column, expiration of approval, of row 182, Fenoxaprop-P, the date is replaced by ‘30 November 2026’; (k) in the sixth column, expiration of approval, of row 187, Flutolanil, the date is replaced by ‘15 June 2026’; (l) in the sixth column, expiration of approval, of row 232, Gibberellic acid, the date is replaced by ‘31 October 2026’; (m) in the sixth column, expiration of approval, of row 233, Gibberellins, the date is replaced by ‘31 October 2026’; (n) in the sixth column, expiration of approval, of row 295, Paraffin oil, the date is replaced by ‘30 November 2026’. 2. Part B of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (a) in the sixth column, expiration of approval, of row 24, Fluxapyroxad, the date is replaced by ‘31 October 2027’; (b) in the sixth column, expiration of approval, of row 43, Bixafen, the date is replaced by ‘31 October 2027’; (c) in the sixth column, expiration of approval, of row 48, Sedaxane, the date is replaced by ‘31 October 2027’; (d) in the sixth column, expiration of approval, of row 57, Penthiopyrad, the date is replaced by ‘31 October 2027’; (e) in the sixth column, expiration of approval, of row 68, 1,4-Dimethylnaphthalene, the date is replaced by ‘30 November 2027’; (f) in the sixth column, expiration of approval, of row 86, Halauxifen-methyl, the date is replaced by ‘5 January 2028’; (g) in the sixth column, expiration of approval, of row 88, Sulfoxaflor, the date is replaced by ‘18 January 2028’; (h) in the sixth column, expiration of approval, of row 120, Bentazone, the date is replaced by ‘31 October 2027’. 3. In Part E of the Annex to Implementing Regulation (EU) No 540/2011, in the sixth column, expiration of approval, of row 9, Propyzamide, the date is replaced by ‘30 November 2027’.
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.